trending Market Intelligence /marketintelligence/en/news-insights/trending/gsuhpc_yo8oek-hfjgxzeg2 content esgSubNav
In This List

Calyxt begins follow-on common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Calyxt begins follow-on common stock offering

Calyxt Inc. began a follow-on public offering of 3,050,000 common shares.

The New Brighton, Minn.-based company intends to grant underwriters a 30-day option to buy up to an additional 457,500 common shares.

Citigroup, Goldman Sachs & Co. LLC and Jefferies are acting as book-running managers with Wells Fargo Securities as lead manager and BMO Capital Markets as co-manager for the proposed offering.

France's Cellectis SA owns about 79.1% of Calyxt, a consumer-centric food- and agriculture-focused biotechnology company.

Calyxt launched its IPO in 2017, raising about $64.4 million in gross proceeds.